Mars Inc.'s $9.1B Acquisition of VCA: A New Era for Pet Healthcare

Mars, Inc.'s Successful Acquisition of VCA Inc.: A New Era for Pet Healthcare

Summary:

Mars, Incorporated has successfully completed the acquisition of VCA Inc., a move that solidifies its commitment to the pet care industry. The $93 per share deal valued at approximately $9.1 billion was signed on January 9th, 2017 by Mars and VCA.

As part of this transaction, VCA will continue to operate indepently under Mars Petcare's umbrella alongside other veterinary services businesses like BANFIELD Pet Hospital, BLUEPEARL Specialty and Emergency Pet Hospitals, and PET PARTNERS Veterinary Hospitals. Bob Antin, a co-founder of VCA, will remn at the helm as CEO, with headquarters remning in Los Angeles, California.

Mars Petcare President, Poul Weihrauch, welcomed the employees of VCA to Mars' family and expressed excitement about this significant step towards delivering comprehensive care for pets. The integration of VCA's expertise in veterinary services, diagnostics, technology, and partnerships with veterinarians will strengthen Mars' position in offering a better world for pets.

Financial Advisors:

Morgan Stanley Co. LLC and BDT Co advised Mars on the transaction while Skadden, Arps, Slate, Meagher Flom served as Mars' legal advisor. Simpson Thacher Bartlett provided legal advice for the debt financing involved.

Barclays was VCA's exclusive financial advisor with Akin Gump Strauss Hauer Feld LLP serving as its legal advisor.

J.P. Morgan Co provided financing support to Mars for this acquisition.

Mars, Incorporated:

As a global business with over $35 billion in sales and more than 85,000 Associates worldwide, Mars is renowned for producing some of the world's best-loved brands across various sectors including confectionery MM’s, SNICKERS, snacks TWIX, MILKY WAY, DOVE, health wellness products PEDIGREE, ROYAL CANIN, WHISKAS, beverages and cereals.

Not only is Mars dedicated to quality, responsibility, mutuality, efficiency, and freedom in business operations but it also focuses on the betterment of pets through its veterinary care services. This commitment aligns with Mars Petcare's overarching purpose - A BETTER WORLD FOR PETS.

VCA Animal Hospitals:

VCA is a leader in pet healthcare committed to shaping the future of veterinary medicine. As an integral part of the Mars Veterinary Health family, VCA enhance pet and lives through its network of local animal hospitals dedicated to delivering high-quality medical care. The company provides general practice services along with emergency and specialty care for millions of pets each year.

VCA's 35,000+ employees include around 7,000 veterinarians including nearly 430 board-certified specialists, approximately 4,000 credentialed technicians, and over 10,000 veterinary assistants who are committed to providing the best possible care for pets.

VCA's social responsibility efforts include continuous investment in cutting-edge tools, trning, and technology that fosters innovation within the industry. The acquisition by Mars strengthens VCA's commitment towards its purpose of creating a better world for pets.

For more information on Mars Petcare or VCA Animal Hospitals, visit their respective websites.

Contact Information:

Mars, Incorporated:

Brunswick Group

Blake Sonnenshein

212 333-3810

VCA Inc.

Tomas W. Fuller

Chief Financial Officer

310 571-6505

Legal : This information is and may require updating to match the most current data.

The enhanced version offers a more polished narrative with an emphasis on key points that enhance clarity and , while mntning accuracy. The language has been adapted to provide a comprehensive overview of the acquisition detls and related entities in an English-speaking context.
This article is reproduced from: https://vcahospitals.com/press-center/vca-news/mars-acquisition

Please indicate when reprinting from: https://www.o058.com/Pet_Hospital_Animal_Hospital/MARS_VCA_Acquisition_Overview.html